Japan, June 10 -- ONO PHARMACEUT CO LTD has got intellectual property rights for 'CANCER THERAPY BY COMBINATION WITH CD47 INHIBITORY SUBSTANCE, IMMUNE CHECKPOINT INHIBITORY SUBSTANCE AND STANDARD THERAPY.' Other related details are as follows:

Application Number: JP,2024-157591

Category (FI): A61K39/395@N,A61K39/395@U,A61P35/04,A61K31/519,A61K31/513,A61K31/282,A61K39/395@T,A61P43/00,121,A61K45/00,A61P35/00

Stage: Grant (IP right document published.)

Filing Date: Sept. 11, 2024

Publication Date: Dec. 17, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....